News Breaks |
|
|
| September 25, 2012 |
| 08:10 EDT |  | SVA | Sinovac Biotech awarded tenders for Hep A vaccine
Sinovac Biotech announced that it has been selected by the Beijing Health Bureau and the Shanghai Centers for Disease Control and Prevention to supply the company's inactivated hepatitis A vaccine, Healive, to the Expanded Program of Immunization for each city. The tenders awarded to Sinovac in Beijing and Shanghai are valued at approximately RMB20M and RMB13M, respectively. |
|
|
News For SVA From The Last 14 Days Check below for free stories on SVA the last two weeks. |
|
|
| May 15, 2013 |
| 09:37 EDT |  | SVA | Sinovac Biotech upgraded to Equal Weight from Underweight at Morgan Stanley
|
|
| 06:15 EDT | | SVA | Sinovac Biotech appoints Ernst & Young Hua Ming China as external auditor
 Subscribe for More Information |
|
|
|
|
|
